En español
NIDA

NIDAMED News

Marijuana drug use increasing during pregnancy

January 29, 2018 | Science Highlight

A “New Vista” for Treating Cocaine Addiction

January 17, 2018 | Science Highlight

Oxytocin protocol appears workable and safe for methadone patients who use cocaine

January 09, 2018 | Science Highlight
Some 30 to 60 percent of patients in methadone maintenance therapy (MMT) for opioid use disorders use cocaine. Compared to other MMT patients, those who use cocaine have higher rates of relapse and mortality. Studies with animals have suggested that the hormone oxytocin could be doubly helpful to these patients, by reducing the addictive effects of both opioids and cocaine. Now, researchers supported by the National Institute on Drug Abuse have developed a protocol for adjunctive oxytocin treatment, and a pilot study has indicated that it is workable and safe for MMT patients.

Opioid treatment drugs have similar outcomes once patients initiate treatment

November 14, 2017 | News Release
NIDA study compares buprenorphine/naloxone combination to extended release naltrexone.

Substance Use Disorders Are Associated With Major Medical Illnesses and Mortality Risk in a Large Integrated Health Care System

October 24, 2017 | NIDA Notes

Strong associations exist between substance use disorder diagnoses and 19 major medical illnesses among patients in a large, integrated health care system. The study indicates that these associations may persist even in health care systems that provide specialized treatment for substance use disorders and have capacity to integrate behavioral and medical care.

New Medication Formulations Could Quickly Make a Difference for Treating Opioid Addiction

August 22, 2017 | Nora's Blog
As Francis Collins and I wrote in May, NIH and NIDA are committed to an “all scientific hands on deck” effort to end the opioid crisis in America by halving the time it takes to develop new medications to treat pain and addiction and reverse overdoses.